Inventor · disambiguated record
Jian-Xin Duan
Also filed as: DUAN JIAN-XIN
20 granted patents·9 pending applications·141 citations·filing 1997–2020
94Inventor score
Files withTHRESHOLD PHARMACEUTICALS INC13OBI PHARMA INC5MOLECULAR TEMPLATES INC3MATTEUCCI MARK2AMMONS STEVE1
Top patents by PatentIndex Score
29 records- 0189US8299088B2Compositions and methods for treating cancerMATTEUCCI MARK·Filed 2009·Granted Oct 30, 2012·21 cites·11 claims
- 0289US8003625B2Phosphoramidate alkylator prodrugsTHRESHOLD PHARMACEUTICALS INC·Filed 2006·Granted Aug 23, 2011·12 cites·20 claims
- 0388US8575188B2Camptothecin derivativesCAI XIAOHONG·Filed 2010·Granted Nov 5, 2013·11 cites·17 claims
- 0487US8507464B2Phosphoramidate alkylator prodrugsMATTEUCCI MARK·Filed 2011·Granted Aug 13, 2013·10 cites·20 claims
- 0587US6392097B1Process for the preparation of derivatives of octafluoro-[2,2] paracylophaneSPECIALTY COATING SYSTEMS INC·Filed 2001·Granted May 21, 2002·21 cites·16 claims
- 0685US5841005AParylene AF4 synthesisFiled 1997·Granted Nov 24, 1998·32 cites·42 claims
- 0779US10766914B2DNA alkylating agentsOBI PHARMA INC·Filed 2019·Granted Sep 8, 2020·1 cites·14 claims
- 0879US8946275B2Treatment of cancer using hypoxia activated prodrugsKROLL STEWART·Filed 2009·Granted Feb 3, 2015·8 cites·18 claims
- 0979US7550496B2Compositions and methods for treating cancerTHRESHOLD PHARMACEUTICALS INC·Filed 2004·Granted Jun 23, 2009·13 cites·18 claims
- 1077US8664204B2Phosphoramidate alkylator prodrugsTHRESHOLD PHARMACEUTICALS INC·Filed 2013·Granted Mar 4, 2014·2 cites·9 claims
- 1176US10364261B2DNA alkylating agentsOBI PHARMA INC·Filed 2016·Granted Jul 30, 2019·2 cites·11 claims
- 1274US10131683B2TH-302 solid forms and methods related theretoMOLECULAR TEMPLATES INC·Filed 2015·Granted Nov 20, 2018·1 cites·16 claims
- 1373US9226932B2Phosphoramidate alkylator prodrugsTHRESHOLD PHARMACEUTICALS INC·Filed 2013·Granted Jan 5, 2016·1 cites·13 claims
- 1472US10409869B2(R)- and (S)-1-(3-(3-N,N-dimethylaminocarbonyl)phenoxyl-4-nitrophenyl)-1-ethyl-N,N'-bis (ethylene)phosphoramidate, compositions and methods for their use and preparationOBI PHARMA INC·Filed 2016·Granted Sep 10, 2019·1 cites·20 claims
- 1572US8552048B2Phosphoramidate alkylator prodrugs for the treatment of cancerAMMONS STEVE·Filed 2007·Granted Oct 8, 2013·5 cites·27 claims
- 1665US10654876B2TH-302 solid forms and methods related theretoMOLECULAR TEMPLATES INC·Filed 2018·Granted May 19, 2020·0 cites·18 claims
- 1764US10668047B2Aziridine containing DNA alkylating agentsMOLECULAR TEMPLATES INC·Filed 2019·Granted Jun 2, 2020·0 cites·11 claims
- 1861US11535585B2Nitrobenzyl derivatives of anti-cancer agentsOBI PHARMA INC·Filed 2020·Granted Dec 27, 2022·0 cites·19 claims
- 1959US8765690B2Treatment of cancer with glufosfamide in patients not receiving insulin therapyHANDISIDES DAMIAN·Filed 2008·Granted Jul 1, 2014·0 cites·10 claims
- 2057US2015272973A1Treatment of Cancer with Glufosfamide in Patients Not Receiving Insulin TherapyTHRESHOLD PHARMACEUTICALS INC·Filed 2014·Application pending·0 cites
- 2152US2018169064A1Aziridine containing dna alkylating agentsTHRESHOLD PHARMACEUTICALS INC·Filed 2016·Application pending·0 cites
- 2250US10829437B2Nitrobenzyl derivatives of anti-cancer agentsOBI PHARMA INC·Filed 2016·Granted Nov 10, 2020·0 cites·16 claims
- 2350US2015258125A1Treatment of cancer using hypoxia activated prodrugsTHRESHOLD PHARMACEUTICALS INC·Filed 2014·Application pending·0 cites
- 2445US2009042820A1Tubulin Binding Anti Cancer Agents And Prodrugs ThereofTHRESHOLD PHARMACEUTICALS INC·Filed 2005·Application pending·0 cites
- 2545US2008214576A1Topoisomerase Inhibitors and ProdrugsTHRESHOLD PHARMACEUTICALS INC·Filed 2005·Application pending·0 cites
- 2645US2007015771A1Lonidamine analogsTHRESHOLD PHARMACEUTICALS INC·Filed 2006·Application pending·0 cites
- 2745US2007043057A1Lonidamine analogsTHRESHOLD PHARMACEUTICALS INC·Filed 2006·Application pending·0 cites
- 2845US2007060534A1Anthracycline analogsTHRESHOLD PHARMACEUTICALS INC·Filed 2006·Application pending·0 cites
- 2944US2008132458A1Hypoxia-Activated Anti-Cancer AgentsTHRESHOLD PHARMACEUTICALS INC·Filed 2005·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →